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A B S T R A C T
Suicidal behavior is a major health risk in psychiatric disorders, especially in affective and psychotic disorders. The
neurobiology of suicidal behavior is still unclear. Suicidality has been related to a reduced cholesterol levels. The aim of
this study was to evaluate serum cholesterol concentrations in suicidal and non-suicidal men suffering from persistent
delusional disorder and in healthy volunteers. Results showed that serum cholesterol concentrations were significantly
lower in suicidal than in non-suicidal patients and healthy controls. Also, level of psychopathology (measured by Brief
Psychiatric Rating Scale) is significantly marked in the group of suicidal patients, which indicates the importance of de-
tecting some clinical symptoms in patients with persistent delusional disorder in order to prevent suicidal behavior.
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Introduction
Persistent delusional disorder is characterized by the
development either of a single delusion or of a set of re-
lated delusions which are usually persistent and some-
times lifelong. Other psychopathology is characteristi-
cally absent, but depressive symptoms may be present
intermittently, and olfactory and tactile hallucinations
may develop in some cases. Clear and persistent auditory
hallucinations (voices), schizophrenic symptoms such as
delusions of control and marked blunting of affect, and
definite evidence of brain disease are all incompatible
with this diagnosis. Onset is commonly in middle age but
sometimes, particularly in the case of beliefs about hav-
ing a misshapen body, in early adult life1. The suicidal be-
havior is a major risk in psychotic patients such as pa-
tients suffering from persistent delusional disorder2. The
rate of suicide in psychotic patients is more than 20 times
higher than that in the general population3–4. The neuro-
biology of suicide in psychoses is still unclear. Various
studies5–6 aimed at identifying the possible peripheral
markers that might help in the early detection of suicidal
behavior. While there are a lot of data regarding the biol-
ogy of suicidality in schizophrenia7, the data considering
biology of suicidality in the persistent delusional disorder
are missing.
Among the biological hypotheses of suicidality, low
blood cholesterol level has been extensively explored.
Consistent findings from the large epidemiological stud-
ies provide strong evidence in support of a putative rela-
tionship between low cholesterol levels and suicidal be-
havior, including a completed suicide8. In the early
1990’s, analysis of mortality rates in the primary preven-
tion clinical trials revealed an association between low
cholesterol and unnatural death9–11. The relationship be-
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tween serum cholesterol and suicidality does not seem to
be limited to individuals with certain psychiatric disor-
der. Patients who survived a violent suicide attempts
were found to have lower cholesterol levels than patients
who survived a non-violent suicide attempts12, or than
non-suicidal controls13. This is in line with our previous
reports showing an association between low concentra-
tion of serum cholesterol and violent suicide attempts in
schizophrenic men14–15 and suicidal patients in the first
episode of psychosis16.
Searching the literature, we could not find papers re-
garding neurobiology of suicidal behavior in persistent
delusional disorder. Since the knowledge of the under-
laying neurobiology of suicide might contribute to the
prevention of the suicidal act, we hypothesized that male
suicidal patients suffering from persistent delusional dis-
order will have different serum cholesterol than non-sui-
cidal patients.
Materials and Methods
Subjects
Participants were male patients, mean age of 32.02±
8.21 years, admitted to the Department of Psychiatry,
University Hospital Zagreb, during the period of 18
months. The diagnosis of the persistent delusional disor-
der was done according to the ICD-X criteria17.
Their demographic data are given in Tables 1 and 2.
Inclusion and exclusion criteria
All patients were free of all medications in the previ-
ous 4 weeks. Within patients, 20 patients were consecu-
tively admitted suicidal men with diagnosis of persistent
delusional disorder, and 20 patients were consecutively
admitted men with same diagnosis, without suicidal be-
havior. Healthy male subjects (N=20) with no history of
psychiatric illness and suicidal behavior were randomly
selected as a control group. They were closely matched
for age. All subjects gave written informed consent to
participate in the study. This study was approved by the
Clinical Hospital Center Medical Ethics Committee.
None of the patients or control subjects included in
the study had used any cholesterol-lowering drugs before
the sampling. The exclusion criteria were: hypertension,
hypothyroidism, diabetes mellitus, disorders of the lipo-
protein metabolism, diagnosis of substance abuse, in-
cluding alcoholism, eating disorders and organic brain
syndrome.
Biochemical determination
Blood samples were collected from all subjects at 8.00
a.m. after an overnight fasting, and serum concentration
of cholesterol was determined enzymatically, immedi-
ately after the blood collection. The assays were done us-
ing commercial kits (Olympus Diagnostic GmbH, Ham-
burg, Germany) on Olympus AU 600 automatic analyzer.
Body mass index (BMI) was used as a marker of the di-
etary habits.
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TABLE 1
AGE, BMI AND CHOLESTEROL (X±SD) IN MALE SUICIDAL AND NON-SUICIDAL PATIENTS SUFFERING FROM PERSISTENT
DELUSIONAL DISORDER AND IN HEALTHY CONTROL SUBJECTS
Characteristic
Suicidal
(N=20)
Non-suicidal
(N=20)
Healthy controls
(N=20)
One-way
ANOVA; F
p
Age (years) 33.70±7.40 31.40±8.26 30.95±9.03 0.638 0.532
BMI (kg/m2) 24.78±2.07 25.16±1.92 25.32±1.76 0.417 0.661
Cholesterol (mmol/L) 4.37±1.00 5.23±1.00 5.09±0.53 5.618 0.006
TABLE 2
SOCIO-DEMOGRAPHIC CHARACTERISTICS OF MALE SUICIDAL AND NON-SUICIDAL PATIENTS
Characteristics Suicidal Non-suicidal c2 test p
Family status: N 0.235 0.118
Living alone 2 6
Living with family 18 14
Education: 3.034 0.552
Elementary school 3 4
High school 16 15
Faculty 1 1
Family history of suicide or suicide attempt: 1.600 0.206
Positive 8 12
Negative 12 8
Clinical Evaluations
The trained psychiatrists performed clinical evalua-
tion. The Brief Psychiatric Rating Scale – BPRS18, was
administered to assess a broad range of psychopathology.
Patients were classified as suicidal at the hospital admis-
sion if a suicidal ideation, or a suicide attempt, or both,
were present. Suicidality was defined if patients had 2 or
more scores on the BPRS, on the item 4 (item on suicide).
Non-suicidal patients had score 1 on the BPRS item 4.
Statistical analysis
The results were expressed as mean ± SD. All data
were evaluated using one-way analysis of variance (ANO-
VA) followed by a Scheffee’s multiple comparison test.
When two groups were compared, Student’s t-test was
used. Because age and BMI might influence cholesterol
levels, these variables were included as covariates within
analysis of covariance (ANCOVA) in the comparison of
serum cholesterol levels. The differences in the socio-de-
mographic variables between suicidal and non-suicidal
groups were assessed using Chi square (c2) test. A signifi-
cance was accepted when p<0.05. Statistical analyses
were performed with the statistical package SPSS ver-
sion 10 for Windows.
Age of the patients and body mass index (BMI) did not
differ significantly between suicidal and non-suicidal pa-
tients and healthy control groups (Table 1). Serum cho-
lesterol levels were significantly different (F=5,618; df=
2; p=0.006, ANOVA) between suicidal (4.37±1.00 mmol/L),
non-suicidal (5.23±1.00 mmol/L) patients and healthy
(5.09±0.53 mmol/L) male subjects (Table 1). Serum cho-
lesterol levels were significantly reduced in suicidal when
compared to non-suicidal patients (p=0.011, Scheffe’s
test), and healthy controls (p=0.038, Scheffe’s test).
These results remained after controlling for age and BMI
(ANCOVA).
The demographic characteristics of the subjects are
shown in Table 2. There were no significant differences
in the occurence in the socio-demographic variables be-
tween suicidal and non-suicidal male patients: in the
family status (living alone or in family), degree of educa-
tion, and family history of suicide or suicide attempt
(Table 2). Suicidal patients, compared to non-suicidal pa-
tients, had more cases of family history of suicidal beha-
vior, but these differences were not significant (Table 2).
The BPRS score were significantly (Student’s t-test)
higher in suicidal compared to non-suicidal patients (Ta-
ble 3). Nine of 24 symptoms on BPRS were significantly
higher in suicidal patients, compared to non-suicidal pa-
tients (Table 3). We have applied test of correlation for
cholesterol and each symptom of BPRS and have not
found any significant correlation for cholesterol.
The main finding of the present study was signifi-
cantly lower total serum cholesterol in suicidal patients
suffering from persistent delusional disorder compared
to non-suicidal patients with same diagnosis and healthy
control subjects. The lower cholesterol levels found in
suicidal patients suffering from persistent delusional dis-
order in the present study agree with previously pub-
lished reports14–16,19–21.
Level of psychiatric symptoms (detected by BPRS) is
significantly marked in the group of suicidal patients,
which indicates the importance of detecting some clinical
symptoms in patients with persistent delusional disorder
in order to prevent suicidal behavior. Nine of 24 symp-
toms on BPRS, in present study, were significantly higher
in suicidal suicidal patients, compared to non-suicidal pa-
tients. Spectrum of numerous mentioned symptoms and
lack of significant correlation for cholesterol implies that
suicidality is very complex process containing different
psychopathological elements and interaction between bi-
ological and clinical parameters. A larger sample size of
suicidal delusional disorder patients would be necessary
to clarify what aspect of the disorder accounts for sui-
cidality.
An association between lower serum cholesterol con-
centrations and increased suicidal risk has been de-
scribed in the literature. Several different mechanisms
have been suggested to explain the potential effect of low
cholesterol levels on suicidality. Biological evidence link-
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TABLE 3
BPRS (X±SD) IN MALE SUICIDAL AND NON-SUICIDAL PATIENTS SUFFERING FROM PERSISTENT DELUSIONAL DISORDER
Scale or symptom Suicidal Non-suicidal Student’s test; t p
BPRS total score 79.10±11.93 67.70±9.30 3.370 0.002
Items of BPRS (9 items that significantly differ between groups):
Depression 3.90±1.33 2.65±0.88 3.504 0.001
Suicidality 4.90±1.65 1.00±0.00 10.563 0.000
Unusual thought content 3.85±1.04 2.95±1.04 2.660 0.011
Self-neglect 3.70±0.80 2.50±1.15 3.835 0.000
Conceptual disorganisation 3.10±0.85 2.55±0.83 2.073 0.045
Blunted affect 4.30±1.38 2.45±1.10 4.689 0.000
Tension 4.25±1.29 3.20±1.11 2.761 0.009
Distractibility 4.25±1.12 3.05±1.00 3.580 0.001
Motor hyperactivity 4.05±1.23 3.30±1.08 2.044 0.048
ing cholesterol and suicidality derives from demonstra-
ted relationships between cholesterol concentrations and
serotonin measures. Serotonergic dysfunction is a well-
established explanation for suicidal behavior22–23, a rela-
tionship apparently mediated by increased aggressivi-
ty8,24. Low plasma concentrations of cholesterol in turn,
have been associated with low platelet 5-HT content16,25,
low plasma serotonin concentrations26, and blunted neu-
roendocrine responses to MCPP27 or fenfluramine28.
Hawton29 speculated on the influence of a decreased
serotonergic transmission on suicidal behavior. Steeg-
mans26 described lower plasma 5-HT concentrations in
men with persistent low serum cholesterol concentra-
tions. Although the biological mechanisms of the rela-
tionship between low cholesterol levels and suicide are
still unclear, reduced serum cholesterol may be accompa-
nied by alterations in 5-HT membrane fluidity, viscosity,
and function of 5-HT receptor and 5-HT transporter, and
decrease in 5-HT precursor, tryptophan plasma levels30.
According to high cited Engelbergs hypothesis30, low se-
rum cholesterol levels may be associated with reduced
lipid micro-viscosity in the brain-cell-membrane and may
decrease the exposure of 5-HT receptors on the mem-
brane surface, resulting in decreased serotonergic recep-
tor function Consequently, serotonergic neurotransmi-
ssion may be inhibited, which may lead to a poorer
suppression of impulsive or aggressive behavior, or to a
depressive state, triggering a more violent pattern of be-
havior in susceptible individuals.
In , our findings support the hypothesis of an associa-
tion between suicidal behavior and reduced level of pe-
ripheral biological marker, serum cholesterol. Identify-
ing biological, social, and clinical predictors of suicide
might help to improve the prediction and prevention of
suicide. A better understanding of the neurobiology of
suicide can facilitate the detection of the population of
patients who have a high risk to attempt suicide, and to
develop better treatment interventions for these pati-
ents. Further prospective studies are needed to inves-
tigate whether this peripheral parameter might be used
as the early predictors of suicide behavior.
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SERUMSKE KONCENTRACIJE KOLESTEROLA KOD SUICIDALNIH I NESUICIDALNIH MU[KIH
BOLESNIKA OBOLJELIH OD PERZISTIRAJU]EG SUMANUTOG POREME]AJA
S A @ E T A K
Suicidalno pona{anje jedan je od vode}ih zdravstvenih rizika u psihijatrijskih bolesnika, posebno u afektivnim i psi-
hoti~nim poreme}ajima. Neurobiologija suicidalnog pona{anja jo{ uvijek nije dovoljno obja{njena. Suicidalnost se pove-
zuje sa smanjenom razinom kolesterola. Svrha ovog istra`ivanja bila je evaluirati serumske koncentracije kolesterola u
skupini mu{kih suicidalnih i nesuicidalnih bolesnika s perzistiraju}im sumanutim poreme}ajem te u skupini mu{kih
zdravih kontrolnih ispitanika. Rezultati pokazuju kako kod suicidalnih bolesnika postoji zna~ajno ni`a razina koleste-
rola nego u skupini nesuicidalnih bolesnika i zdravih kontrolnih ispitanika. Tako|er, razina psihopatologije (na skali
BPSR) zna~ajno je nagla{enija u skupini suicidalnih bolesnika, {to ukazuje na va`nost prepoznavanja pojedinih kli-
ni~kih simptoma u bolesnika s perzistiraju}im sumanutim poreme}ajem zbog prevencije suicidalnog pona{anja.
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